The Invenia ABUS Premium device reportedly offers consistent high-resolution imaging and up to a 40 percent increase in scan speeds for women with dense breasts.
For women with dense breasts, the newly launched Invenia ABUS Premium device offers a combination of artificial intelligence (AI) tools and enhanced 3D ultrasound imaging quality to facilitate detection and characterization of breast lesions.
In addition to automated breast ultrasound (ABUS) technology that aids in the detection of malignancies, the Invenia ABUS Premium device offers AI tools such as Scan Quality Assessment, which helps ensure proper coverage and positioning of breasts for scanning, and Auto Nipple Detection for enabling consistent nipple marker positions, according to GE HealthCare, the developer of the Invenia ABUS Premium platform.
Improved imaging resolution with the recently launched Invenia ABUS Premium system reveals smaller hypoechoic lesions in the above case. (Images courtesy of GE HealthCare.)
The company added that a Fast Scan tool with the Invenia ABUS Premium device provides up a 40 percent increase in scan speed, and a combination of the Invenia ABUS Viewer with AI Assistant allows expeditious review and assessment of ultrasound exams.
“Women with dense breasts often face poorer outcomes due to malignancies detected at later, more advanced stages. Invenia ABUS Premium equipped with AI has the potential to optimize clinicians’ screening capabilities, enabling them to detect even small, early-stage cancers with a high degree of confidence in women with dense breasts,” said Karley Yoder, the CEO of Comprehensive Care Ultrasound at GE HealthCare.
GE HealthCare said another key feature with the Invenia ABUS Premium system is the Reverse Curve tranducer, which offers one to maximize patient comfort with selectable compression levels and enables more precise contouring of breast anatomy.
“The new Reverse Curve transducer makes the examination more patient friendly, and it is much more comfortable. There has been great improvement in image quality with less shadowing, and the structures behind the area of the nipple are seen more clearly, providing radiologists with greater diagnostic confidence,” added Athina Vourtsis, M.D., Ph.D, the chief director and founder of Athena Medical in Athens, Greece, and a member of the medical advisory board for DenseBreast-Info.org .
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.